The Patent Finder

Interlude Biopharma Co.

Also on record
Records under this name other than the patents Interlude Biopharma Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.

Showing 1 to 2 of 2 · Back to Interlude Biopharma Co.

PatentTitleStatus Expires Confidence
US 8,796,203Use of Tight Junction Antagonists to Treat Inflammatory Bowel Disease
Lapsed on the fee record
Ended Aug 5, 2026 · High confidence
Lapsed on the fee recordEnded Aug 5, 2026High confidence
US 8,299,017Use of Tight Junction Antagonists to Treat Inflammatory Bowl Disease
Lapsed on the fee record
Ended Oct 30, 2024 · High confidence
Lapsed on the fee recordEnded Oct 30, 2024High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited